Missense mutations in human CaSR gene cause familial hypocalciuric hypercalcemia (FHH) or neonatal severe hyperparathyroidism (NSHPT) dependent on the allele dose [117,118]. Here, CASR is linked to neonatal severe primary hyperparathyroidism.